About: Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 25 October 2010

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2010 (fr) наукова стаття, опублікована в жовтні 2010 (uk) scientific article published on 25 October 2010 (en) artículu científicu espublizáu n'ochobre de 2010 (ast)
publication date	wds:Q82078216-D4E943F3-FEA2-44AA-BA6D-5108374D590E
publication date	2010-10-25 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q82078216-D15737C1-6230-4062-A589-076343A30F5B
language of work or name	English
cites work	wds:Q82078216-0525550D-63AE-4D7F-8A4E-336EBA43A6F0 wds:Q82078216-0B4D69B7-00C2-4B30-84CC-B5C176119D13 wds:Q82078216-14982BA8-F130-48AD-8AA1-5C28007C3A7E wds:Q82078216-17829A45-F75F-43DB-802F-DEEB708A20F6 wds:Q82078216-32B25A18-EEFD-4B88-90A8-5E3E9F3627BB wds:Q82078216-CA8EDFCD-994F-4141-85E5-B48E2E3F71FB wds:Q82078216-DA2A308A-4E04-4013-8162-F52BC298976F
cites work	Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication New strategies for the elimination of polio from India Monovalent type 1 oral poliovirus vaccine in newborns Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study Seroresponse to trivalent oral poliovirus vaccine as a function of dosage interval. Effectiveness of immunization against paralytic poliomyelitis in Nigeria Randomised trial of alternative formulations of oral poliovaccine in Brazil
author name string	wds:Q82078216-5F6C0C04-7624-4AD7-A1F3-64A687ED5135 wds:Q82078216-76E836A7-ABD1-4DDB-B8F8-D80B5B8F0417 wds:Q82078216-8974517B-F8F1-4CA6-9571-C6C0BAEA16A7 wds:Q82078216-F3337090-2B73-497E-93B7-5298D4E81664
author name string	Ajit Pal Singh T Jacob John Hamid Jafari Padmasani Venkat Ramanan
rdfs:label	Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial (en) Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial (nl)
skos:prefLabel	Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial (en) Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial (nl)
name	Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial (en) Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial (nl)
author	wds:Q82078216-0FE6A6E7-B1B6-4265-8865-5C3A5403C819 wds:Q82078216-44AE30E2-AA74-4F8F-BD38-E0F265567AA5 wds:Q82078216-7BBE3ECC-01F5-436D-8F4D-38812C60BE47 wds:Q82078216-93130F9D-D484-41F7-9C35-7571993F0937 wds:Q82078216-C39B10EE-89F5-412A-94BE-918485765168 wds:Q82078216-CD6DB23F-2686-4C4E-B5DC-05BC7910609A wds:Q82078216-CEEED3CA-1471-47FB-B620-B972706DED1B wds:Q82078216-E0D561B2-D647-4AD3-A492-3FD4963DD9D2 wds:Q82078216-ED9A4658-D17B-4CAC-9222-5A323A0E5A52 wds:Q82078216-F305EBCE-EC42-49C1-B341-F3E9224FA054
author	Bruce Aylward Roland W Sutter Jagadish Deshpande Anthony Burton Hemant K Jain Harish Verma Arani Chatterjee Sharad Agarkhedkar Meghana Sreevatsava Pradeep Malankar
title	wds:Q82078216-C4A28B37-2A77-4DAD-AE9C-CCD84F0F295A
title	Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial (en)
page(s)	wds:Q82078216-9BEA6082-30E7-402D-8B5A-EFCC3947B8F6
page(s)	1682-1688
instance of	wds:Q82078216-2180A04D-4F38-4FD5-A74A-3EF3A813A9CE
instance of	scholarly article
main subject	wds:Q82078216-D62A2431-7484-48F2-AB6F-1314D1AEF535
main subject	polio vaccine
PubMed ID	wds:Q82078216-5A79AF31-A1B5-47FB-A9EC-95C361100502
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20980048
PubMed ID	20980048
published in	wds:Q82078216-3382A0E9-61C5-4DCE-9188-3BBFFB17C5C8
published in	The Lancet
issue	wds:Q82078216-A99FD5FC-FCA7-4003-B07D-9F0BA9C7F5AE
volume	wds:Q82078216-1F0924F1-F513-4CB3-9C42-4C26313465FA
issue	9753
volume	376
DOI	wds:Q82078216-95868515-9502-4C7D-ACED-61E4757E24F8
DOI	http://dx.doi.org/10.1016/S0140-6736(10)61230-5
DOI	10.1016/S0140-6736(10)61230-5
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q82078216
is cites work of	So close: remaining challenges to eradicating polio The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis Oral polio vaccine response in breast fed infants with malnutrition and diarrhea Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria Development of newborn and infant vaccines The role of research in viral disease eradication and elimination programs: lessons for malaria eradication The global polio eradication initiative: lessons learned and prospects for success The last mile in global poliomyelitis eradication. Expert review on poliovirus immunity and transmission Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs The principles and feasibility of disease eradication The final stages of the global eradication of poliomyelitis Key issues in the persistence of poliomyelitis in Nigeria: a case-control study. Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data. Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial Polio-free certification and lessons learned--South-East Asia region, March 2014. Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software